Peripartum kardiomyopati

Ditte-Marie Bretler; Casper Haslund Jørgensen; Jonas Bjerring Olesen; Gunnar Hilmar Gislason; Peter Riis Hansen

Peripartum kardiomyopati

Ditte-Marie Bretler, Casper Haslund Jørgensen, Jonas Bjerring Olesen, Gunnar Hilmar Gislason, Peter Riis Hansen

Abstrakt

Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition.

Bidragets oversatte titel	[Peripartum cardiomyopathy]
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	171
Udgave nummer	1-2
Sider (fra-til)	53-5
Antal sider	3
Status	Udgivet - 5 jan. 2009

Citationsformater

@article{fab3da1044dc4707852b521e9bca41e6,

title = "Peripartum kardiomyopati",

abstract = "Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition.",

author = "Ditte-Marie Bretler and J{\o}rgensen, {Casper Haslund} and Olesen, {Jonas Bjerring} and Gislason, {Gunnar Hilmar} and Hansen, {Peter Riis}",

year = "2009",

month = jan,

day = "5",

language = "Dansk",

volume = "171",

pages = "53--5",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "1-2",

}

TY - JOUR

T1 - Peripartum kardiomyopati

AU - Bretler, Ditte-Marie

AU - Jørgensen, Casper Haslund

AU - Olesen, Jonas Bjerring

AU - Gislason, Gunnar Hilmar

AU - Hansen, Peter Riis

PY - 2009/1/5

Y1 - 2009/1/5

N2 - Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition.

AB - Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition.

M3 - Tidsskriftartikel

C2 - 19128569

VL - 171

SP - 53

EP - 55

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 1-2

ER -

Peripartum kardiomyopati

Abstrakt

Fingeraftryk

Citationsformater